BDBM267176 N-[2-(4,4-difluoropiperidin-1-yl)-2-(1,3-oxazol-5-yl)ethyl]-2,6-dimethylbenzamide::US10167281, Compound 46::US9718812, 46

SMILES Cc1cccc(C)c1C(=O)NCC(N1CCC(F)(F)CC1)c1cnco1

InChI Key InChIKey=DKVVHGBDOCQCAB-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 267176   

TargetP2X purinoceptor 7(Human)
Axxam

US Patent
LigandPNGBDBM267176(N-[2-(4,4-difluoropiperidin-1-yl)-2-(1,3-oxazol-5-...)
Affinity DataIC50: 18nMAssay Description:Extracellular binding of Bz-ATP to P2X7 receptor opens the channel and allows Ca2+ influx into the cells. This Ca2+ entry was measured in HEK-293 cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2018
Entry Details
Go to US Patent

TargetP2X purinoceptor 7(Human)
Axxam

US Patent
LigandPNGBDBM267176(N-[2-(4,4-difluoropiperidin-1-yl)-2-(1,3-oxazol-5-...)
Affinity DataIC50: 55nMAssay Description:YO-PRO -1 is a fluorescent DNA-binding dye with a MW of 374 Da (Molecular Probes, cat. Y3603). This method is based upon the presumed ability of YO-P...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2018
Entry Details
Go to US Patent

TargetP2X purinoceptor 7(Human)
Axxam

US Patent
LigandPNGBDBM267176(N-[2-(4,4-difluoropiperidin-1-yl)-2-(1,3-oxazol-5-...)
Affinity DataIC50: 18nMAssay Description:Extracellular binding of Bz-ATP to P2X7 receptor opens the channel and allows Ca2+ influx into the cells. This Ca2+ entry was measured in HEK-293 cel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 7(Human)
Axxam

US Patent
LigandPNGBDBM267176(N-[2-(4,4-difluoropiperidin-1-yl)-2-(1,3-oxazol-5-...)
Affinity DataIC50: 55nMAssay Description:YO-PRO -1 is a fluorescent DNA-binding dye with a MW of 374 Da (Molecular Probes, cat. Y3603). This method is based upon the presumed ability of YO-P...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetP2X purinoceptor 7(Human)
Axxam

US Patent
LigandPNGBDBM267176(N-[2-(4,4-difluoropiperidin-1-yl)-2-(1,3-oxazol-5-...)
Affinity DataIC50: 18nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetP2X purinoceptor 7(Human)
Axxam

US Patent
LigandPNGBDBM267176(N-[2-(4,4-difluoropiperidin-1-yl)-2-(1,3-oxazol-5-...)
Affinity DataIC50: 18nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed